| Health Technology Assessment 1998; Vol. 2: No. 7 (Executive
summary)
Executive summary
View/Download full
monograph in Adobe Acrobat format (406 kbytes)
View/Download this
4-page summary in Adobe Acrobat format (suitable for printing)
Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomised
controlled trials
F Song
AM Glenny
NHS Centre for Reviews and Dissemination, University of York
Background
Wound infections are the most frequent nosocomial infections among surgical patients
and are related to an increase in morbidity and mortality, a prolongation of hospital stay
and an increase in the cost of medical care. Colorectal surgery is associated with a high
risk of infection due to endogenous contamination by bacteria in the contents of the large
bowel.
It is now generally accepted that antimicrobial prophylaxis is one of many important
measures that should be taken to prevent postoperative wound infections. To achieve the
most cost-effective use of antimicrobial prophylaxis, consideration of the choice,
delivery and regimen of antimicrobial agents is necessary.
Objectives
This review evaluates the relative efficacy of antimicrobial prophylaxis in patients
undergoing colorectal surgery where there is a high risk of surgical wound infection
(SWI).
Methods
Data sources
Literature searches of Medline, Embase and the Cochrane Controlled Trials Register were
conducted to identify randomised controlled trials (RCTs) published between 1984 and 1995,
which investigated antimicrobial prophylaxis in the prevention of postoperative wound
infection in patients who had undergone colorectal surgery. Bibliographies of review s and
all identified trials were examined to locate additional studies. A sample of key journals
was also handsearched. All languages were considered.
Validity assessment and data extraction
The identified studies were assessed for both relevance and validity by one reviewer
and checked by another. Data extraction was carried out by one reviewer using an
electronic data extraction form. This process was again checked by a second reviewer. For
articles containing insufficient detail, authors were contacted for clarification. Of all
the studies assessed, 147 RCTs, including a total of 23,049 patients, met the review
inclusion criteria.The principal outcome assessed in the review was the incidence of SWI.
Where possible, abdominal wound infections were recorded separately from perineal wound
infections. Data on other postoperative infections and adverse events were also collected.
Data synthesis
Studies were grouped according to the antibiotic used, route of administration, and
number of doses administered (i.e. single versus multiple doses). Where appropriate,
formal meta-analysis and investigation of heterogeneity among trials were conducted.
Results
The quality of the RCTs has improved over the last 12 years, though there are still
many methodological problems, including inappropriate method of patient allocation, lack
of blinding during outcome assessment, and insufficient sample size. The criteria for
inclusion and exclusion were described in 87% of the included trials. The exclusion
criteria most frequently used were allergy to study drugs, preoperative use of other
antibiotics, impaired renal or liver function, children or very old patients, pregnancy or
lactation, and certain types of colorectal operations.
More than 70 different antibiotic regimens were tested in 147 trials. The overall rate
of SWI across all the included trials of antimicrobials prophylaxis (excluding four
non-antibiotic groups) was 11.1% (n = 22,927).
The results of this review confirm that the use of antimicrobial prophylaxis is
generally effective for the prevention of SWIs in colorectal surgery. Some antimicrobial
regimens appear to be less effective than others in this indication. For example,
monotherapy with either metronidazole, doxycycline or piperacillin are inadequate for
prophylactic treatment in colorectal surgery.
The review found that a single dose or short-term use of an antimicrobial agent is as
efficacious as long-term, postoperative use. Pooled results from 17 trials that compared a
single-dose regimen with a multiple-dose regimen, showed no significant difference in the
rate of SWI (odds ratio = 1.17; 95% confidence interval [CI]: 0.89, 1.54). There is a lack
of convincing evidence concerning the importance of a second-dose regimen when surgical
procedures are longer than 2 hours.
There is no convincing evidence to suggest that the second- and third-generation
cephalosporins are more efficacious than the first-generation cephalosporins in this
indication (6% versus 6.4%; odds ratio = 0.93; 95% CI: 0.46, 1.86).
Establishing the efficacy of different routes of administration of antibiotic
prophylaxis was complicated by the use of different antibiotics or use of extra
antibiotics. No additional benefit was observed in six trials that compared parenteral
alone, with parenteral plus topical use of antibiotic prophylaxis. Several trials, showing
extra benefit of oral antibiotics, used inadequate parenteral antibiotics such as
metronidazole alone, or piperacillin alone. Oral or topical application of antibiotics in
addition to the parenteral administration of appropriate antibiotics seem to be of limited
value in most cases.
In general, the estimates of efficacy of many of the different regimens included are
similar and it is very difficult, if not impossible, to identify the best one. However,
the Type-II error or lack of statistical power cannot be ruled out as a potential reason
for statistically non-significant findings in many small trials.
A total of 74 of the 134 trials published in English reported adverse events following
antibiotic prophylaxis in colorectal surgery. Skin rash, diarrhoea, and nausea were
commonly mentioned adverse events that may be attributable to the use of some antibiotic
treatments. No serious toxicity or adverse events were reported except in one trial that
reported postoperative bleeding in some patients treated with latamoxef.
The costs associated with SWI are high in terms of both antibiotic treatment and
prolonged hospitalisation with some studies reporting an additional 12 days in hospital as
a result of SWI. Three trials that included cost data in comparisons of monotherapy and
combination therapy showed that monotherapy was as effective as the combination regimens
but less expensive. The overall cost data available from the RCTs suggest that drug
acquisition costs need to be viewed in terms of their efficacy, as a reduction in
infection rates is associated with a shorter hospital stay, the 'hotel' costs of which
account for the highest proportion of overall cost during treatment.
Conclusions
The use of antimicrobial prophylaxis is efficacious in the prevention of SWI in
colorectal surgery. With the exception of a few inadequate regimens, there is no
significant difference in the rate of SWI between many regimens. The use of a
multiple-dose regimen may be unnecessary for the prevention of SWI, as single-dose
regimens have been demonstrated to be as efficacious as multiple dosing and in addition,
may be associated with less toxicity, fewer adverse events, less risk of developing
bacterial resistance and lower costs. Similarly, no convincing evidence supports the idea
that the new-generation cephalosporins are more efficacious than first-generation
cephalosporins in preventing SWI in colorectal surgery.
Implications for policy
Two principles are important to follow when selecting an antimicrobial prophylactic
regimen in colorectal surgery:
- antibiotics or antibiotic combinations should be active against both aerobic and
anaerobic bacteria;
- the administration of antibiotics should be timed to ensure that the tissue
concentration of antibiotics around the wound area is sufficiently high when bacterial
contamination occurs.
Universal acceptance and use of a regimen should be avoided in order to minimise the
development of antibiotic-resistant bacteria. Based on the research evidence, guidelines
should be developed locally in order to achieve a more cost-effective use of antimicrobial
prophylaxis in colorectal surgery.
Recommendations for research
Further studies of efficacy may be of little value and would require large numbers of
patients in order to demonstrate a statistically significant difference. Future research
should focus on the understanding of the practical use of antimicrobial prophylaxis in
colorectal surgery in the UK and the cost-effectiveness of different regimens of
antibiotic prophylaxis.
Publication
Song F, Glenny. AM. Antimicrobial prophylaxis in colorectal surgery: a
systematic review of randomised controlled trials. Health Technol Assessment
1998; 2(7).
NHS R&D HTA Programme
The overall aim of the NHS R&D Health Technology Assessment (HTA)
programme is to ensure that high quality research information on the costs, effectiveness
and broader impact of health technologies is produced in the most efficient way for those
who use, manage and work in the NHS. Research is undertaken in those areas where the
evidence will lead to the greatest benefits to patients, either through improved patient
outcomes or the most efficient use of NHS resources.
The Standing Group on Health Technology advises on national priorities
for health technology assessment. Six advisory panels assist the Standing Group in
identifying and prioritising projects. These priorities are then considered by the HTA
Commissioning Board supported by the National Coordinating Centre for HTA.
This report is one of a series covering acute care, diagnostics and
imaging, methodology, pharmaceuticals, population screening, and primary and community
care. The views expressed in this publication are those of the authors and not necessarily
those of the Standing Group, the Commissioning Board or the Panel members.
Reviews in Health Technology Assessment are termed 'systematic'
when the account of the search, appraisal and synthesis methods (to minimise biases and
random errors) would, in theory, permit the replication of the review by others.
Series Editors:
Andrew Stevens, Ruairidh Milne, Ken Stein
Assistant Editor:
Jane Robertson, Jane Royle The editors have tried to ensure the accuracy of this report
but cannot accept responsibility for any errors or omissions. They would like to thank the
referees for their constructive comments on the draft document.
©1998 Crown Copyright |